BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MassBioEd Life Sciences Career Hub - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://careerhub.massbioed.org
X-WR-CALDESC:Events for MassBioEd Life Sciences Career Hub
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251014T090000
DTEND;TZID=America/New_York:20251015T170000
DTSTAMP:20251014T224538Z
CREATED:20250718T221529Z
LAST-MODIFIED:20251014T224538Z
UID:3305-1760432400-1760547600@careerhub.massbioed.org
SUMMARY:Biotech Commercialization: From Approval to Access (NEW) – October 2025
DESCRIPTION:Members of LabOps Unite\, please register here.\nMembers of Bio CT\, please register here.\nPlease view the discount options for courses before registering here.\n\n\nMember Rate: $1\,275 \n\n\nNon-Member Rate: $1\,500 \n\n\nInterested in offering the training exclusively to a group of your employees? Email courses@massbioed.org to learn more.\nDescription \nThis advanced course explores the critical intersection of biotechnology\, business\, and regulatory frameworks\, equipping participants with the knowledge and strategies needed to successfully bring biotech innovations to market. Covering key areas such as regulatory approval pathways\, pricing and reimbursement dynamics\, market access\, and commercialization strategies\, this course provides a comprehensive roadmap for navigating the complexities of biotech product launch and market adoption. Through interactive lectures\, case studies\, and a hands-on capstone project\, participants will gain practical insights into market assessment\, go-to market planning\, strategic partnerships\, and financial feasibility.  \n\n\nDate & Time\nTuesday\, October 14th\, 2025\, 9:00 AM – 5:00 PM EST \nWednesday\, October 15th\, 2025\, 9:00 AM – 1:00 PM EST\n\n\n\n\nPlease plan to arrive at least 15 minutes before class starts. Class will start at 9:00 AM. We will have breaks in between. \nThis course will be held in-person. Breakfast and lunch will be provided at this all day workshop.  \nAgenda\nRegulatory Pathways & Market Assessment \n\nOverview of global regulatory frameworks (FDA\, EMA\, PMDA\, etc.)\nRole of Health Technology Assessment (HTA) bodies in market access\nMarket opportunity analysis: TAM\, SAM\, SOM\, and competitive landscape\nUnderstanding customer needs and decision-making processes\n\nCommercialization & Go-to-Market Strategy \n\nDeveloping a commercialization roadmap\nSales and distribution models for biotech innovations\nKey partnerships\, licensing\, and business development strategies\nMarketing\, branding\, and customer engagement for biotech products\n\nPricing\, Reimbursement & Financial Strategy \n\nPricing models\, reimbursement mechanisms\, and value-based agreements\nClinical indication sequencing and long-term pricing strategy\nFunding mechanisms: venture capital\, grants\, and partnerships\nFinancial feasibility and ROI evaluation for commercialization\n\nCapstone Project: Commercialization Plan & Presentation \n\nTeam-based development of a commercialization plan for a biotech product\nPresentation of strategy\, including regulatory approach\, financial model\, and market entry plan\nGroup feedback and expert insights\n\nInstructors\n\nJohn Tagliamonte\nChief Executive Officer\, Mellitus\n \nBusiness \n\n\nJohn Tagliamonte has more than 30 years of experience in executive leadership with responsibility for business development\, finance\, commercial and business operations\, strategic planning\, finance and legal functions with established and emerging public and private life sciences companies.  As the first Entrepreneur-in-Residence with MassBio\, he was responsible for forward-looking program content across the organization\, while helping to develop the next generation of biotech entrepreneurs. He currently serves on the business advisory boards of therapeutic startups WntRx\, Fractal\, MarkTx\, PhagePro and Tantu.  Previously he led business development at Juniper\, was Chief Business Officer of Oxyrane and held various executive business leadership roles at Anchor Therapeutics\, ImmunoGen and Johnson & Johnson\, as well as venture investing with Safeguard.  He began his career as a scientist at Dana-Farber Cancer Institute followed by global business unit management at Bio-Rad.  Mr. Tagliamonte received his M.B.A. from Boston College and his B.S. in molecular biology from Tufts University. \n\n\n\n\nAtul Deshpande\, Ph.D.\, MBA\nChief Strategy Officer\, Peptilogics \nBusiness \nAtul Deshpande is the Chief Strategy Officer at Peptilogics\, a clinical stage AI/ML driven peptide therapeutics company\, where he is responsible for corporate strategy and business development. Prior to that he was the Chief Executive Officer of IMMEDIATE Therapeutics\, a clinical stage biotech company dedicated to developing safe and effective therapeutic solutions to reduce heart muscle damage and prevent cardiac arrest in Acute Coronary Syndromes (ACS)\, the most common cause of death and morbidity across the world. Atul spent 3 years in China as the Head of Asia Pacific R&D strategy to bring the global portfolio to China with minimal drug lag. Before Sanofi\, Atul worked as a management consultant for 9 years on projects across the value chain of pharma. Atul holds a Ph.D. from UC Irvine in Neuroscience and a post-doc from UCLA.
URL:https://careerhub.massbioed.org/event/biotech-commercialization-from-approval-to-access-new-october-2025/
LOCATION:MassBioEd Office (The Link)\, 255 Main Street\, Cambridge\, MA\, 02142\, United States
CATEGORIES:Industry Professionals
ATTACH;FMTTYPE=image/jpeg:https://careerhub.massbioed.org/wp-content/uploads/2025/03/green-header-2-7GvhOB.tmp_.jpg
END:VEVENT
END:VCALENDAR